It’s a biotech environment without many good choices. Even before President Donald Trump’s tariff announcement pushed stock ...

HHS and 19 other government agencies can follow through with firing thousands of probationary workers after a federal appeals ...

Novo Nordisk invests $1.05B in Brazil factory to boost GLP-1 drug production, including Wegovy and Ozempic, creating 600 jobs ...

FDA removes safety program requirement for Idorsia's blood pressure drug Tryvio, Solu gets $41M Series A with Eli Lilly backing, Vincerx shutters, Cytora reports stem cell win in ulcers ...

The nonprofit drug pricing watchdog Institute for Clinical and Economic Review on Wednesday released a new report outlining ...

FDA staff cuts could trigger user fee clawback mechanism, but experts including Patrick Frey and David Risinger say immediate ...

Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...

Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in a case that will consider the extent to ...

To make sense of the stock selloff that started late last week, Endpoints News’ Max Bayer and Drew Armstrong spoke to Leerink ...

The state of the US biosimilar market isn't as healthy as it should be despite significant advances in the past decade, ...

The Trump administration on Tuesday said it will challenge a federal judge’s order that blocks its planned 15% rate limit on ...

GSK pays ABL Bio $49.5M upfront for blood-brain barrier platform access, with potential $2.67B in milestone payments. Deal ...